Mixing Time Effects on the Dispersion Performance of Adhesive Mixtures for Inhalation

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Grasmeijer, Floris ^a   Hagedoorn, Paul ^a   Frijlink, Henderik W ^a   de Boer, H Anne ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FLUTICASONE PROPIONATE; LACTOSE; SALMETEROL XINAFOATE;

ARTICLE; DISPERSION; DRUG MIXTURE; FLOW RATE; INHALATION; INHALER; LASER DIFFRACTION; MECHANICAL STRESS; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY;

ADMINISTRATION, INHALATION; ALBUTEROL; ANDROSTADIENES; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; LACTOSE; LASERS; MICROSCOPY, ELECTRON, SCANNING; PARTICLE SIZE; SOLUBILITY; TIME FACTORS; X-RAY DIFFRACTION;

EID: 84879756294     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0069263     Document Type: Article

References (27)

1. Lacey PMC, (1997) The mixing of solid particles. Chem Eng Res Des 75 (Supplement),:: S49-S55. doi:10.1016/S0263-8762(97)80004-4.
2. Hersey JA, (1975) Ordered mixing: A new concept in powder mixing practice. Powder Technol 11: 41-44. doi:10.1016/0032-5910(75)80021-0.
3. Staniforth JN, (1981) Total Mixing. Int J Pharm Tech Prod Mfr 2: 7-12.
4. Staniforth JN, (1987) British Pharmaceutical Conference Science Award Lecture 1986: Order out of chaos. J Pharm Pharmacol 39: 329-334. doi:10.1111/j.2042-7158.1987.tb03393.x. PubMed: 2886579.
5. Kale K, Hapgood K, Stewart P, (2009) Drug agglomeration and dissolution- What is the influence of powder mixing? Eur J Pharm Biopharm 72: 156-164. doi:10.1016/j.ejpb.2008.12.015. PubMed: 19347972.
6. de Villiers MM, Lötter AP, van der Watt JG, (1993) Influence of surfactants and interactive mixing on the cohesive properties of a poorly wettable solid. Powder Technol 75: 159-165. doi:10.1016/0032-5910(93)80077-N.
7. de Boer AH, Hagedoorn P, Gjaltema D, Lambregts D, Irngartinger M, et al. (2004) The Mode of Drug Particle Detachment from Carrier Crystals in an Air Classifier-Based Inhaler. Pharm Res 21: 2167-2174. doi:10.1007/s11095-004-5171-6. PubMed: 15648247.
8. Travers DN, (1975) Some observations on ordered mixing of micronized sodium-bicarbonate with sucrose crystals. Powder Technol 12: 189-190. doi:10.1016/0032-5910(75)80011-8.
9. de Boer AH, Hagedoorn P, Gjaltema D, Goede J, Kussendrager KD, et al. (2003) Air classifier technology (ACT) in dry powder inhalation Part 2. The effect of lactose carrier surface properties on the drug-to-carrier interaction in adhesive mixtures for inhalation. Int J Pharm 260: 201-216. doi:10.1016/S0378-5173(03)00264-3. PubMed: 12842340.
10. Kulvanich P, Stewart PJ, (1987) The effect of blending time on particle adhesion in a model interactive system. J Pharm Pharmacol 39: 732-733. doi:10.1111/j.2042-7158.1987.tb06978.x. PubMed: 2890739.
11. Lam KK, Newton JM, (1991) Investigation of applied compression on the adhesion of powders to a substrate surface. Powder Technol 65: 167-175. doi:10.1016/0032-5910(91)80179-M.
12. Podczeck F, (1996) Assessment of the mode of adherence and the deformation characteristics of micronized particles adhering to various surfaces. Int J Pharm 145: 65-76. doi:10.1016/S0378-5173(96)04718-7.
13. Bridson RH, Robbins PT, Chen Y, Westerman D, Gillham CR, et al. (2007) The effects of high shear blending on α-lactose monohydrate. Int J Pharm 339: 84-90. doi:10.1016/j.ijpharm.2007.02.022. PubMed: 17398047.
14. Shur J, Harris H, Jones MD, Kaerger JS, Price R, (2008) The role of fines in the modification of the fluidization and dispersion mechanism within dry powder inhaler formulations. Pharm Res 25: 1631-1640. doi:10.1007/s11095-008-9538-y. PubMed: 18239861.
15. Dickhoff BHJ, de Boer AH, Lambregts D, Frijlink HW, (2003) The effect of carrier surface and bulk properties on drug particle detachment from crystalline lactose carrier particles during inhalation, as function of carrier payload and mixing time. Eur J Pharm Biopharm 56: 291-302. doi:10.1016/S0939-6411(03)00109-7. PubMed: 12957644.
16. de Boer AH, Dickhoff BHJ, Hagedoorn P, Gjaltema D, Goede J, et al. (2005) A critical evaluation of the relevant parameters for drug redispersion from adhesive mixtures during inhalation. Int J Pharm 294: 173-184. doi:10.1016/j.ijpharm.2005.01.035. PubMed: 15814242.
17. Le VNP, Robins E, Flament MP, (2012) Agglomerate behaviour of fluticasone propionate within dry powder inhaler formulations. Eur J Pharm Biopharm 80: 596-603. doi:10.1016/j.ejpb.2011.12.004. PubMed: 22198291.
18. Dickhoff BHJ, Ellison MJH, de Boer AH, Frijlink HW, (2002) The effect of budesonide particle mass on drug particle detachment from carrier crystals in adhesive mixtures during inhalation. Eur J Pharm Biopharm 54: 245-248. doi:10.1016/S0939-6411(02)00082-6. PubMed: 12191698.
19. Begat P, Morton DAV, Staniforth JN, Price R, (2004) The Cohesive-Adhesive Balances in Dry Powder Inhaler Formulations II: Influence on Fine Particle Delivery Characteristics. Pharm Res 21: 1826-1833. doi:10.1023/B:PHAM.0000045236.60029.cb. PubMed: 15553229.
20. Jones MD, Hooton JC, Dawson ML, Ferrie AR, Price R, (2008) An Investigation into the Dispersion Mechanisms of Ternary Dry Powder Inhaler Formulations by the Quantification of Interparticulate Forces. Pharm Res 25: 337-348. doi:10.1007/s11095-007-9467-1. PubMed: 17952568.
21. Elamin AA, Ahlneck C, Alderborn G, Nyström C, (1994) Increased metastable solubility of milled griseofulvin, depending on the formation of a disordered surface structure. Int J Pharm 111: 159-170. doi:10.1016/0378-5173(94)00132-4.
22. Mosharraf M, Nyström C, (1999) The effect of dry mixing on the apparent solubility of hydrophobic, sparingly soluble drugs. Eur J Pharm Sci 9: 145-156. doi:10.1016/S0928-0987(99)00043-3. PubMed: 10620727.
23. de Boer AH, Hagedoorn P, Gjaltema D, Goede J, Frijlink HW, (2003) Air classifier technology (ACT) in dry powder inhalation: Part 1. Introduction of a novel force distribution concept (FDC) explaining the performance of a basic air classifier on adhesive mixtures. Int J Pharm 260: 187-200. doi:10.1016/S0378-5173(03)00250-3. PubMed: 12842339.
24. Price R, (2010) Low and High Energy Blending. Presentation at conference: Lactose as a carrier for inhalation products. Parma.
25. Hüttenrauch R, Fricke S, Zielke P, (1985) Mechanical Activation of Pharmaceutical Systems. Pharm Res 2: 302-306. doi:10.1023/A:1016397719020.
26. Mosharraf M, Nyström C, (2003) Apparent Solubility of Drugs in Partially Crystalline Systems. Drug Dev Ind Pharm 29: 603-622. doi:10.1081/DDC-120021310. PubMed: 12889779.
27. Cordts E, Grasmeijer F, Van der Wel P, Dekens B, De Boer AH, et al. (2012) The influence of mixing time and intensity on blend homogeneity and dispersion performance. Drugs Deliv Lungs 23. Edinburgh. pp. 146-149.